Radical blow for snotty arteries
13 May 2009
Controlling the green stuff in snot could help treat heart disease, reveals Professor Michael Davies from the Faculty of Medicine and the Heart Research Institute.
In an exciting discovery, researchers from The University of Sydney, the Free Radical Centre at the Heart Research Institute (HRI), and the Queensland University of Technology have found agents that could stop the progression of heart disease by preventing damage by an enzyme also found in snot.
"It might sound disgusting, but the same goop that makes snot green gets dumped in our arteries during heart disease", Professor Davies.
Snot appears green due to the presence of the enzyme, myeloperoxidase.
Myeloperoxidase is normally called into action by our immune systems to kill off bacteria. It does this by making the powerful oxidant hypochlorous acid - the main ingredient in household bleach.
"Although hypochlorous acid is a vital component of the body's defence system against bacteria, it is also highly reactive and can damage tissues when produced in the wrong place, at the wrong time or at excessive levels," warns Professor Davies.
"This has been shown to contribute to a number of diseases such as atherosclerosis, asthma, rheumatoid arthritis and some cancers", he adds.
"Because of the common occurrence and far reaching medical consequences of these diseases, we wanted to find a safe way of controlling myeloperoxidase", comments Professor Davies.
The team has developed antioxidant compounds called nitroxides that are very effective at preventing myeloperoxidase from producing hypochlorous acid. There is now considerable hope that the discovery will lead to a new drug to treat heart disease and other inflammatory diseases.
"Nitroxide compounds are very exciting", he says. "Finding drugs that can tame the green goop in arteries is a very important step forward. We think nitroxides have great potential to improve and save the lives of many!"
The group's work will be published in the upcoming edition of the international scientific journal Biochemical Journal.
DrMartin Rees from the Centre for Vascular Research at the University of New South Wales was also a lead investigator in this study.
Contact: Jacob O'Shaughnessy
Phone: 02 9351 4312